Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies.
Fingolimod induces neuroprotective factors in human astrocytes.
Astrocytes Promote Oligodendrogenesis after White Matter Damage via Brain-Derived Neurotrophic Factor.
Changes of synapses in experimental autoimmune encephalomyelitis by using Fasudil.
Development and initial validation of the Perceptions of Parental Illness Questionnaire (PPIQ).
Cognitive but not affective theory of mind deficits in mild relapsing-remitting multiple sclerosis.
Reported outcomes after the endovascular treatment of chronic cerebrospinal venous insufficiency.
Similar autobiographical memory impairment in long-term secondary progressive multiple sclerosis and Alzheimer's disease.
IL-17-Induced Act1-Mediated Signaling Is Critical for Cuprizone-Induced Demyelination.
Neuromyelitis Optica Preceded by HyperCKemia and a Possible Association with Coxsackie Virus Group A10 Infection.
Theranostic implications of nanotechnology in multiple sclerosis: a future perspective.
Polymorphisms of paraoxonase 1 and 2 genes and the risk of multiple sclerosis in the Polish population.
Estimating the Cost-Effectiveness of OnabotulinumtoxinA for Neurogenic Detrusor Overactivity in the United States.
A phase-specific neuroimmune model of clinical depression.
Cannabinoids decrease the th17 inflammatory autoimmune phenotype.
Lower motor neuron involvement in longitudinally extensive transverse myelitis with and without aquaporin-4 antibodies.
Pediatric multiple sclerosis: update in diagnosis and management.
Evidence linking HHV-6 with multiple sclerosis: an update.
Influence of corpus callosum damage on cognition and physical disability in multiple sclerosis: a multimodal study.
Anti-JC virus antibody titres increase over time with natalizumab treatment.
GeNeuro Announces the Launch of Phase IIb Proof-of-Concept Study with GNbAC1 in Multiple Sclerosis and Servier Equity Investment
Therapeutic decision making in a new drug era in multiple sclerosis.
2-photon imaging of phagocyte-mediated T cell activation in the CNS.
Combined sequence-based and genetic mapping analysis of complex traits in outbred rats.
High-dose methylprednisolone-induced hepatitis in a patient with multiple sclerosis: A case report and brief review of literature.
Pages
« first
‹ previous
…
256
257
258
259
260
261
262
263
264
…
next ›
last »